From Wikipedia, the free encyclopedia
|This article relies largely or entirely upon a single source. (August 2014)|
|Systematic (IUPAC) name|
|Molecular mass||450.55 g/mol|
|(what is this?)|
Acotiamide (YM-443, Z-338) is a drug approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. It acts as an acetylcholinesterase inhibitor.
- Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H (January 2010). "Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage". Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society 22 (6): 618–e173. doi:10.1111/j.1365-2982.2009.01449.x. PMID 20059698.
|This article about an amine is a stub. You can help Wikipedia by expanding it.|
|This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.|